Regions Financial Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

Regions Financial Corp’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$392K	Sell	1,302 -171	-12%	-$51.6K	﹤0.01%	670
2026 Q1	$487K	Buy	+1,473	New	+$501K	﹤0.01%	615
2019 Q2	–	Sell	-5	Closed	–	–	853
2019 Q1	$0	Hold	5	–	–	﹤0.01%	1925
2018 Q4	$0	Hold	5	–	–	﹤0.01%	1898
2018 Q3	$0	Sell	5 -5	-50%	-$503	﹤0.01%	1961
2018 Q2	$1K	Buy	+10	New	+$992	﹤0.01%	1974
2014 Q4	–	Sell	-4,362	Closed	-$341K	–	933
2014 Q3	$341K	Sell	4,362 -378	-8%	-$24.4K	﹤0.01%	881
2014 Q2	$299K	Buy	+4,740	New	+$282K	﹤0.01%	943

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Regions Financial Corp's ALNY Position: Q2 2026 in Review

Regions Financial Corp reduced its Alnylam Pharmaceuticals (ALNY) stake by 12% in Q2 2026, selling an estimated $51.6K and leaving 1,302 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Regions Financial Corp first reported a position in ALNY in Q2 2014 and has held it in 8 quarters since. The position peaked at $487K in Q1 2026. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Regions Financial Corp held 1,302 shares of Alnylam Pharmaceuticals worth $392K as of Q2 2026.
Regions Financial Corp sold 171 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $51.6K.
Alnylam Pharmaceuticals made up ﹤0.01% of Regions Financial Corp's portfolio in Q2 2026, its #670 holding.
Regions Financial Corp first reported a position in Alnylam Pharmaceuticals in Q2 2014 and has held it in 8 quarters since.
Regions Financial Corp's Alnylam Pharmaceuticals position peaked at $487K in Q1 2026.
793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.